miRagen Therapeutics Inc (MGEN)
Cours de l'action
Résultats financiers
Value bought
90 derniers jours
Value sold
90 derniers jours
Net insiders buying
90 derniers jours
Trades (buy and sell)
90 derniers jours
Rechercher
| Date de notification | Date de transaction | A/V Type de transaction | Initié et/ou titre |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 2024-09-27 | AP Achat planifié |
Chief Operating Officer Dirigeant |
5 000
+500.0%
23,41117 050 USD |
5 000 +500.0% | 23,41 | 117 050 USD | |
| 2024-09-30 | 2024-09-27 | A Achat |
President and CEO Administrateur exécutif |
21 400
+inf%
23,33499 262 USD |
21 400 +inf% | 23,33 | 499 262 USD | |
| 2024-09-17 | 2024-09-13 | A Achat |
Fairmount Funds Management LLC Administrateur non-exécutif Actionnaire important |
1 600 000
+86.7%
18,7530 000 000 USD |
1 600 000 +86.7% | 18,75 | 30 000 000 USD | |
| 2024-01-24 | 2024-01-22 | A Achat |
Fairmount Funds Management LLC See Remarks Administrateur non-exécutif Actionnaire important |
476 190
+34.9%
21,009 999 990 USD |
476 190 +34.9% | 21,00 | 9 999 990 USD | |
| 2023-06-20 | 2023-06-16 | V Vente |
Chief Legal Officer Dirigeant |
27
-0.1%
28,35765 USD |
27 -0.1% | 28,35 | 765 USD | |
| 2023-06-20 | 2023-06-15 | VP Vente planifiée |
Chief Legal Officer Dirigeant |
2 269
-7.0%
28,0263 577 USD |
2 269 -7.0% | 28,02 | 63 577 USD | |
| 2023-06-06 | 2023-06-06 | V Vente |
Chief Legal Officer Dirigeant |
5 126
-14.6%
25,02128 253 USD |
5 126 -14.6% | 25,02 | 128 253 USD | |
| 2023-06-06 | 2023-06-05 | V Vente |
Chief Legal Officer Dirigeant |
499
-1.6%
25,0312 490 USD |
499 -1.6% | 25,03 | 12 490 USD | |
| 2023-06-06 | 2023-06-02 | VP Vente planifiée |
Chief Legal Officer Dirigeant |
1 875
-5.9%
24,2145 394 USD |
1 875 -5.9% | 24,21 | 45 394 USD | |
| 2023-04-12 | 2023-04-12 | A Achat |
Chief Executive Officer Administrateur exécutif |
4 000
+1.6%
25,37101 479 USD |
4 000 +1.6% | 25,37 | 101 479 USD | |
| 2023-03-13 | 2023-03-13 | A Achat |
Chief Executive Officer Administrateur exécutif |
5 500
+2.2%
29,15160 324 USD |
5 500 +2.2% | 29,15 | 160 324 USD | |
| 2023-03-10 | 2023-03-09 | VP Vente planifiée |
General Counsel and Secretary Dirigeant |
29 971
-100.0%
29,07871 257 USD |
29 971 -100.0% | 29,07 | 871 257 USD | |
| 2023-02-03 | 2023-02-02 | VP Vente planifiée |
Chief Executive Officer Administrateur exécutif |
50 000
-10.4%
36,801 840 000 USD |
50 000 -10.4% | 36,80 | 1 840 000 USD | |
| 2023-01-25 | 2023-01-23 | VP Vente planifiée |
General Counsel and Secretary Dirigeant |
6 843
-100.0%
35,66244 021 USD |
6 843 -100.0% | 35,66 | 244 021 USD | |
| 2023-01-18 | 2023-01-17 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
24 853
-100.0%
37,21924 780 USD |
24 853 -100.0% | 37,21 | 924 780 USD | |
| 2023-01-18 | 2023-01-13 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
4 147
-100.0%
37,01153 480 USD |
4 147 -100.0% | 37,01 | 153 480 USD | |
| 2023-01-11 | 2023-01-10 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
47 377
-100.0%
35,301 672 408 USD |
47 377 -100.0% | 35,30 | 1 672 408 USD | |
| 2023-01-11 | 2023-01-09 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
12 623
-100.0%
33,04417 064 USD |
12 623 -100.0% | 33,04 | 417 064 USD | |
| 2022-12-22 | 2022-12-21 | VP Vente planifiée |
General Counsel and Secretary Dirigeant |
16 326
-100.0%
29,19476 556 USD |
16 326 -100.0% | 29,19 | 476 556 USD | |
| 2022-12-22 | 2022-12-20 | VP Vente planifiée |
General Counsel and Secretary Dirigeant |
600
-100.0%
28,0716 842 USD |
600 -100.0% | 28,07 | 16 842 USD | |
| 2022-12-19 | 2022-12-16 | VP Vente planifiée |
General Counsel and Secretary Dirigeant |
1 297
-100.0%
28,4436 887 USD |
1 297 -100.0% | 28,44 | 36 887 USD | |
| 2022-12-19 | 2022-12-15 | VP Vente planifiée |
General Counsel and Secretary Dirigeant |
300
-100.0%
28,088 424 USD |
300 -100.0% | 28,08 | 8 424 USD | |
| 2022-12-14 | 2022-12-14 | VP Vente planifiée |
General Counsel and Secretary Dirigeant |
15 656
-100.0%
28,12440 247 USD |
15 656 -100.0% | 28,12 | 440 247 USD | |
| 2022-12-14 | 2022-12-12 | VP Vente planifiée |
General Counsel and Secretary Dirigeant |
600
-100.0%
28,0516 830 USD |
600 -100.0% | 28,05 | 16 830 USD | |
| 2022-11-16 | 2022-11-15 | VP Vente planifiée |
General Counsel and Secretary Dirigeant |
8 125
-100.0%
22,05179 156 USD |
8 125 -100.0% | 22,05 | 179 156 USD | |
| 2022-08-19 | 2022-08-17 | A Achat |
Fairmount Funds Management LLC Administrateur non-exécutif Actionnaire important |
425 531
+45.4%
23,509 999 979 USD |
425 531 +45.4% | 23,50 | 9 999 979 USD | |
| 2022-06-02 | 2022-06-01 | VP Vente planifiée |
Chief Executive Officer Administrateur exécutif |
30 000
-5.9%
12,20366 000 USD |
30 000 -5.9% | 12,20 | 366 000 USD | |
| 2022-05-04 | 2022-05-02 | VP Vente planifiée |
Chief Executive Officer Administrateur exécutif |
30 000
-5.5%
13,04391 200 USD |
30 000 -5.5% | 13,04 | 391 200 USD | |
| 2022-04-05 | 2022-04-04 | VP Vente planifiée |
Chief Executive Officer Administrateur exécutif |
3 600
-0.7%
18,9368 148 USD |
3 600 -0.7% | 18,93 | 68 148 USD | |
| 2022-04-05 | 2022-04-01 | VP Vente planifiée |
Chief Executive Officer Administrateur exécutif |
26 400
-4.6%
18,92499 488 USD |
26 400 -4.6% | 18,92 | 499 488 USD | |
| 2022-03-03 | 2022-03-02 | VP Vente planifiée |
Chief Executive Officer Administrateur exécutif |
11 106
-1.9%
17,36192 800 USD |
11 106 -1.9% | 17,36 | 192 800 USD | |
| 2022-03-03 | 2022-03-01 | VP Vente planifiée |
Chief Executive Officer Administrateur exécutif |
18 894
-3.1%
17,82336 691 USD |
18 894 -3.1% | 17,82 | 336 691 USD | |
| 2022-02-03 | 2022-02-03 | VP Vente planifiée |
Chief Executive Officer Administrateur exécutif |
909
-0.2%
19,1617 416 USD |
909 -0.2% | 19,16 | 17 416 USD | |
| 2022-02-03 | 2022-02-02 | VP Vente planifiée |
Chief Executive Officer Administrateur exécutif |
12 340
-2.0%
18,47227 920 USD |
12 340 -2.0% | 18,47 | 227 920 USD | |
| 2022-02-03 | 2022-02-01 | VP Vente planifiée |
Chief Executive Officer Administrateur exécutif |
16 751
-2.7%
19,55327 482 USD |
16 751 -2.7% | 19,55 | 327 482 USD | |
| 2021-09-28 | 2021-09-23 | A Achat |
Frazier Life Sciences Public Fund, L.P. Actionnaire important |
200 000
+15.3%
11,002 200 000 USD |
200 000 +15.3% | 11,00 | 2 200 000 USD | |
| 2020-11-16 | 2020-11-13 | A Achat | Actionnaire important |
126 667
+29.9%
14,841 879 599 USD |
126 667 +29.9% | 14,84 | 1 879 599 USD | |
| 2020-11-16 | 2020-11-09 | A Achat | Actionnaire important |
100 000
+1.6%
1,16116 410 USD |
100 000 +1.6% | 1,16 | 116 410 USD | |
| 2020-11-16 | 2020-11-09 | A Achat | Actionnaire important |
250 000
+4.2%
1,10274 475 USD |
250 000 +4.2% | 1,10 | 274 475 USD | |
| 2018-10-12 | 2018-10-11 | A Achat |
Hughes Thomas E. Administrateur non-exécutif |
10 000
+353.7%
4,7747 697 USD |
10 000 +353.7% | 4,77 | 47 697 USD | |
| 2018-02-13 | 2018-02-13 | A Achat |
Levy Adam Scott Chief Business Officer Dirigeant |
9 090
+626.9%
5,5049 995 USD |
9 090 +626.9% | 5,50 | 49 995 USD | |
| 2018-02-13 | 2018-02-13 | A Achat |
Booth Bruce Administrateur non-exécutif |
545 454
+67.7%
5,502 999 997 USD |
545 454 +67.7% | 5,50 | 2 999 997 USD | |
| 2017-12-22 | 2017-12-20 | V Vente |
Hughes Thomas E. |
12 000
-80.9%
8,0096 000 USD |
12 000 -80.9% | 8,00 | 96 000 USD | |
| 2017-06-23 | 2017-06-22 | A Achat |
Levy Adam Scott Chief Business Officer |
200
+inf%
7,551 510 USD |
200 +inf% | 7,55 | 1 510 USD | |
| 2017-03-13 | 2017-03-10 | V Vente |
LEFKOFF KYLE Administrateur non-exécutif |
3 300
-0.7%
14,3147 229 USD |
3 300 -0.7% | 14,31 | 47 229 USD | |
| 2017-03-13 | 2017-03-09 | V Vente |
LEFKOFF KYLE Administrateur non-exécutif |
2 500
-0.5%
14,3835 962 USD |
2 500 -0.5% | 14,38 | 35 962 USD | |
| 2017-03-08 | 2017-03-08 | V Vente |
LEFKOFF KYLE Administrateur non-exécutif |
5 000
-1.1%
14,7073 514 USD |
5 000 -1.1% | 14,70 | 73 514 USD | |
| 2017-03-08 | 2017-03-06 | V Vente |
LEFKOFF KYLE Administrateur non-exécutif |
608
-0.1%
16,249 874 USD |
608 -0.1% | 16,24 | 9 874 USD | |
| 2017-03-08 | 2017-03-06 | V Vente |
LEFKOFF KYLE Administrateur non-exécutif |
9 392
-1.9%
15,71147 590 USD |
9 392 -1.9% | 15,71 | 147 590 USD | |
| 2017-02-28 | 2017-02-28 | V Vente |
LEFKOFF KYLE Administrateur non-exécutif |
2 258
-0.5%
13,5430 580 USD |
2 258 -0.5% | 13,54 | 30 580 USD | |
| 2017-02-28 | 2017-02-27 | V Vente |
LEFKOFF KYLE Administrateur non-exécutif |
1 500
-0.3%
13,7920 687 USD |
1 500 -0.3% | 13,79 | 20 687 USD | |
| 2017-02-28 | 2017-02-24 | V Vente |
LEFKOFF KYLE Administrateur non-exécutif |
6 500
-1.3%
14,0491 252 USD |
6 500 -1.3% | 14,04 | 91 252 USD | |
| 2017-02-24 | 2017-02-23 | V Vente |
LEFKOFF KYLE Administrateur non-exécutif |
1 800
-0.4%
13,6524 566 USD |
1 800 -0.4% | 13,65 | 24 566 USD | |
| 2017-02-24 | 2017-02-22 | V Vente |
LEFKOFF KYLE Administrateur non-exécutif |
4 102
-0.8%
14,3658 886 USD |
4 102 -0.8% | 14,36 | 58 886 USD | |
| 2015-11-23 | 2015-11-20 | A Achat |
Riccitelli Samuel D President & CEO Administrateur exécutif |
7 000
+2.1%
0,805 600 USD |
7 000 +2.1% | 0,80 | 5 600 USD | |
| 2015-11-23 | 2015-11-19 | A Achat |
Riccitelli Samuel D President & CEO Administrateur exécutif |
7 000
+2.1%
0,785 460 USD |
7 000 +2.1% | 0,78 | 5 460 USD |